Back to list

Real World Evidence Director, IHD (80-100%)

On Tuesday, May 12,

Offer criteria

  • Director
  • Bâle
  • Permanent contract
  • Full Time
  • Fields of expertise: Forums , Design , Parts , Strategy , Drug Development See more , Innovation , Education , Immunology , Medical Affairs , Guides , Schedule , Support , Development Projects , Decision making , Board , Functional programming , Quantitative , Mapping , Innovative , Demonstration , Transformation , Matrix , Health services , Microsoft Access , Approach , Determination , Data collection , Licensing , Risk , Options , Must , Franchise , Medical , Flexible , Can , Pharmaceutical , Reporting , Foreign exchange , Availability , Advisory , Pharmaceutical Companies , Clear Show less

Company: Novartis

Job description

195 countries and thousands of patients worldwide need support to access new innovative treatments in Immunology, Hepatology and Dermatology (IHD)! With your expertise, we will systematically integrate access in how we research, develop and deliver new medicines globally. Be part of the team that is working on launching 6 potential blockbusters in the next 6 years.

Your responsibilities will include:
• To ensure a broad understanding of the value of RWE to the product value demonstration both globally and locally. Lead and ensure innovative, best-in-class evidence planning and creation, to improve value of key development projects, products, and businesses in key geographies. Drives awareness on impactful use of secondary data across the franchise
• In priority disease areas, lead a cross-functional Real World Evidence team, consisting of representatives from cross-functional teams, embedded within a franchise and being a liaison to team members of the RWE team. With the clear objective to deliver and communicate scientifically valid and meaningful RWE to actively address the varying evidence requirements of partners e.g. Medical Societies, HCPs, Payers (HTA, Regional, Local), Regulators, Patient Groups
• Utilize a decision matrix to determine with Medical Affairs / Patient Access / Safety / Product teams the most suitable source of RWD and RWE generation approach that meets prioritized evidence needs. Where secondary data is not available to generate fit-for-purpose evidence recommend the most appropriate prospective data collection study design and analysis that achieves the objectives. Provides input and supports to develop high quality functional and cross-functional plans
• To implement and ensure uniform excellence standards across franchises for development and reporting of RWE studies. Member of the Integrated Scientific Review Committee (ISRC) with key oversight and advisory responsibility related to post-approval activities (including e.g. global/local phase IV, non-interventional studies, safety commitments). Chair Virtual Concept Review Forum a subcommittee of the ISRC, and guide CPOs on development of study concepts that are aligned with the franchise RWE strategy
• Lead innovation pilots that can support to overcome key challenges in drug development using RWD or enable to provide meaningful RWE in support of regulatory decision making (e.g. label changes, new indications). Responsible for applying innovative RWE study design and statistical analysis to address the key research questions for the product and the Franchise
• To work with regions and country colleagues on mapping of RWD sources, building research collaborations to increase the availability of fit-for-purpose RWD, licensing RWD that support local evidence generation in a robust and credible way

Profile description

What you'll bring to the role:
• Advanced degree or equivalent education/degree in life science/healthcare required.
• 6-8 year's experience acquired at pharmaceutical companies, academia, or relevant consultancy companies
• Deep understanding of Medical Affairs, Market Access/ HEOR, Safety or related disciplines to generate value evidence from retrospective and prospective studies.
• Very strong understanding of drug development and commercial disciplines, proven ability to identify key evidence needs for Commercial, Market access, Medical, Safety, Regulatory stakeholders and lead a team towards building the required insights
• Considerable experience in planning, creation, and analysis of real-world data, from both prospective and retrospective studies with a proven success record in this field
• Experienced and with a strong knowledge of research methodology and statistical methods in the field of prospective clinical data analysis
• Considerable experience in collaborating with quantitative scientists and analysts
• Deep understanding of pharmaceutical value chain and its business processes
• Ability to communicate effectively and motivate team alongside having a persuasive and credible presentation style at all levels of organization

Desirable Requirements:
• Previous work experiences in country organizations a strong plus
• Knowledge of the IHD disease area

WHY CONSIDER NOVARTIS?

750 million. That's how many lives our products touch. And while we're proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people's lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you're given opportunities to explore the power of digital and data. Where you're empowered to risk failure by taking calculated risks, and where you're surrounded by people who share your determination to tackle the world's toughest medical challenges.
We are Novartis. Join us and help us reimagine medicine.


*Some restrictions on flexible working options may apply and will be discussed during interview if applicable.

Salary and benefits

Salary: according to profile


Reference: 292263BR


Create your profile to apply for this job

I accept the terms and conditions so that I can create my account, enjoy matching services and apply for jobs. :